TCR2 Therapeutics Inc. (TCRR)

NASDAQ: TCRR · IEX Real-Time Price · USD
2.88
-0.02 (-0.86%)
Jul 1, 2022 1:18 PM EDT - Market open

Stock Price Forecast

According to 15 stock analysts, the average 12-month stock price forecast for TCRR stock is $14.17, which predicts an increase of 392.87%. The lowest target is $2.02 and the highest is $30.45. On average, analysts rate TCRR stock as a buy.
Analyst Consensus: Buy
Target Low Average Median High
Price $2.02 $14.17 $15.3 $30.45
Change -29.74% +392.87% +432.17% +959.13%

Analyst Ratings

The average analyst rating for TCRR stock from 15 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jan '22Feb '22Mar '22Apr '22May '22Jun '22
Strong Buy 333333
Buy 1088888
Hold 343444
Sell 000000
Strong Sell 000000
Total 161514151515

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.08
EPS Next Year
-2.41
Year 2017201820192020202120222023202420252026
Revenue
-------12.36M12.72M13.36M
Revenue Growth
--------
2.94%
5.00%
EPS
-39.94-98.53-4.62-2.40-2.63-3.08-2.41-2.16-2.46-2.85
EPS Growth
----------
No. Analysts -----1110844

Revenue Forecast

Revenue 20222023202420252026
High n/a n/a 51.9M 13.4M 13.9M
Avg n/a n/a 12.4M 12.7M 13.4M
Low n/a n/a n/a 12.3M 13.0M

Revenue Growth

Revenue Growth 20222023202420252026
High - - -
8.1%
9.2%
Avg - - -
2.9%
5.0%
Low - - -
-0.1%
1.9%

EPS Forecast

EPS 20222023202420252026
High -2.45 -1.32 -0.83 -2.58 -2.97
Avg -3.08 -2.41 -2.16 -2.46 -2.85
Low -3.45 -4.66 -4.22 -2.38 -2.77

EPS Growth

EPS Growth 20222023202420252026
High - - - - -
Avg - - - - -
Low - - - - -